Science

From Psilocybin to MDMA: Researchers are in the throes of a psychedelic revival

Those who reported a “mystical experience” had the most success in breaking their addiction. Griffiths’s lab pressed ahead with their work in a 2014 study on the possibility of treating nicotine addiction with psilocybin, the psychedelic component of “magic mushrooms.” Participants had three psilocybin sessions and three cognitive-behavioral therapy sessions to diminish cravings. Eighty percent…

READ MORE
Science

Rolling in the deep

“So far the studies indicate that MDMA assisted psychotherapy significantly reduces PTSD symptoms”. Although MDMA has been administered to more than 1,000 subjects with only one report of an unexpected serious adverse event (which ended when the drug wore off), the drug doesn’t come without risks. It can increase heart rate and blood pressure and…

READ MORE
Science

Neuroimaging in moderate mdma use: A systemic Review

There is no convincing evidence that moderate MDMA use is associated with structural or functional brain alterations in neuroimaging measures. The lack of significant results was associated with high methodological heterogeneity in terms of dosages and co-consumption of other drugs, low quality of studies and small sample sizes. Original Article (Elsevier): Neuroimaging in moderate MDMA…

READ MORE
Science

The Peace Drug

Bilmes, who has studied the ongoing costs of the wars, estimates that treating Iraq vets with PTSD over the next 50 years will cost taxpayers $100 billion. Vets with PTSD are particularly costly to the [Veterans Affairs] system,” says Linda Bilmes, a lecturer in public policy at Harvard’s Kennedy School of Government. “They constitute 8…

READ MORE